2-(6-Bromo-2,3-dihydro-benzo[1,4]dioxin-2-yl)-4,5-dihydro-1H-imidazole

ID: ALA168773

PubChem CID: 44380902

Max Phase: Preclinical

Molecular Formula: C11H11BrN2O2

Molecular Weight: 283.13

Molecule Type: Small molecule

This compound is available for customization.

Associated Items:

Names and Identifiers

Canonical SMILES:  Brc1ccc2c(c1)OCC(C1=NCCN1)O2

Standard InChI:  InChI=1S/C11H11BrN2O2/c12-7-1-2-8-9(5-7)15-6-10(16-8)11-13-3-4-14-11/h1-2,5,10H,3-4,6H2,(H,13,14)

Standard InChI Key:  NXUJKJDBQASYIB-UHFFFAOYSA-N

Molfile:  

     RDKit          2D

 16 18  0  0  0  0  0  0  0  0999 V2000
    1.7875   -2.2417    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    1.0667   -1.8250    0.0000 O   0  0  0  0  0  0  0  0  0  0  0  0
    2.5000   -1.8292    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.3542   -3.0667    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.3542   -2.2417    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    2.5875   -1.0125    0.0000 N   0  0  0  0  0  0  0  0  0  0  0  0
    1.0667   -3.4792    0.0000 O   0  0  0  0  0  0  0  0  0  0  0  0
    3.2542   -2.1667    0.0000 N   0  0  0  0  0  0  0  0  0  0  0  0
   -0.3583   -3.4792    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    1.7875   -3.0667    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   -0.3583   -1.8292    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   -1.0708   -3.0667    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   -1.0708   -2.2417    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   -1.7875   -3.4792    0.0000 Br  0  0  0  0  0  0  0  0  0  0  0  0
    3.3917   -0.8417    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    3.8042   -1.5542    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
  2  1  1  0
  3  1  1  0
  4  7  1  0
  5  2  1  0
  6  3  2  0
  7 10  1  0
  8  3  1  0
  9  4  2  0
 10  1  1  0
 11  5  2  0
 12  9  1  0
 13 11  1  0
 14 12  1  0
 15  6  1  0
 16  8  1  0
  5  4  1  0
 16 15  1  0
 13 12  2  0
M  END

Associated Targets(non-human)

Adora2b Adenosine A2b receptor (205 Activities)
Activity TypeRelationActivity valueUnitsAction TypeJournalPubMed IddoiAssay Aladdin ID
Adra1b Adrenergic receptor alpha-1 (5652 Activities)
Activity TypeRelationActivity valueUnitsAction TypeJournalPubMed IddoiAssay Aladdin ID

Molecule Features

Natural Product: NoOral: NoChemical Probe: NoParenteral: No
Molecule Type: Small moleculeTopical: NoFirst In Class: NoBlack Box: No
Chirality: NoAvailability: NoProdrug: No

Drug Indications

MESH IDMESH Heading EFO IDsEFO TermsMax Phase for IndicationReferences

Mechanisms of Action

Mechanism of ActionAction Typetarget IDTarget NameTarget TypeTarget OrganismBinding Site NameReferences

Calculated Properties

Molecular Weight: 283.13Molecular Weight (Monoisotopic): 282.0004AlogP: 1.59#Rotatable Bonds: 1
Polar Surface Area: 42.85Molecular Species: BASEHBA: 4HBD: 1
#RO5 Violations: HBA (Lipinski): 4HBD (Lipinski): 1#RO5 Violations (Lipinski):
CX Acidic pKa: CX Basic pKa: 8.62CX LogP: 1.54CX LogD: 0.32
Aromatic Rings: 1Heavy Atoms: 16QED Weighted: 0.85Np Likeness Score: 0.07

References

1. Chapleo CB, Myers PL, Butler RC, Doxey JC, Roach AG, Smith CF..  (1983)  alpha-adrenoreceptor reagents. 1. Synthesis of some 1,4-benzodioxans as selective presynaptic alpha 2-adrenoreceptor antagonists and potential antidepressants.,  26  (6): [PMID:6133953] [10.1021/jm00360a008]

Source